Previous close | 13.70 |
Open | 13.70 |
Bid | 7.40 |
Ask | 11.50 |
Strike | 75.00 |
Expiry date | 2024-10-18 |
Day's range | 13.70 - 13.70 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Strong Aviation Segment Drives Record Q1 Performance, Despite Fleet Challenges
VSE ( NASDAQ:VSEC ) First Quarter 2024 Results Key Financial Results Revenue: US$241.5m (up 28% from 1Q 2023). Net...
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed Steve Griffin as the Company’s Executive Vice President, Chief Financial Officer (“CFO”) and Treasurer, effective June 3, 2024. He succeeds Michael Levitz, who has decided to step down as CFO after almost four years with the compa